相关实验视频

Updated: May 16, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

骨髓造血干细胞活性调节作为心肌梗塞后的治疗策略:一项临床前研究

Jasmin Rettkowski^1,2,3,4, Mari Carmen Romero-Mulero^1,3, Indranil Singh^5,6

¹Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.

Nature cell biology

|April 2, 2025

概括

心肌梗塞 (MI) 损害了骨髓的造血干细胞 (HSC). 用维生素A衍生物向HSC可以减少炎症并改善心脏功能.

科学领域:

心血管研究研究心血管研究
血液学血液学血液学
干细胞生物学干细胞生物学

背景情况:

心肌梗塞 (MI) 是一个重大的全球健康挑战.
虽然髓状细胞有助于心脏病后组织的修复,但过度的骨髓形成会使心脏痕和功能恶化.
骨髓造血干细胞 (HSC) 在心脏病后紧急造血中的作用尚不清楚.

研究的目的:

为了研究心脏病对人类骨髓HSC的影响.
确定HSC是否有助于MI后心脏组织的亲炎性髓状细胞透.
探索针对HSC的治疗策略,以改善心脏病发作后的心脏功能.

主要方法:

从心脏手术患者收集了人类骨髓样本.
在MI后的HSC中分析了转录和功能变化.
利用血统追踪实验来追踪HSC的贡献.
研究了4-oxo-retinoic 酸在强制执行 HSC 静止中的治疗潜力.

主要成果:

肌痛性肌痛诱导人类骨髓HSC中有害的转录和功能变化.
血统追踪表明,HSCs在心脏组织中对MI后的心脏组织中促炎性髓状细胞有所贡献.
用4-oxo-retinoic acid强制执行HSC静止,可以减少炎症性骨髓形成.

结论:

人类骨髓HSC受到MI的负面影响,并导致心脏炎症.
使用4-oxo-retinoic acid治疗强制执行HSC静止,表明它有望调节心脏重塑和保存心脏功能后的MI.

更多相关视频

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

相关概念视频

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...